Related Articles
Determination of prognosis of Philadelphia chromosome‑negative myeloproliferative neoplasms with a simple clinical examination: Retrospective analysis of 71 patients in a single institution
JAK2 V617F detected in two B‑cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome‑negative myeloproliferative neoplasms: A report of two cases
pSTAT5 and ERK exhibit different expression in myeloproliferative neoplasms
Concomitant essential thrombocythemia with JAK2 V617F mutation in a patient with chronic myeloid leukemia with major molecular response with imatinib and long-term follow-up
Detection of JAK2 V617F mutation increases the diagnosis of myeloproliferative neoplasms